Status:
ENROLLING_BY_INVITATION
Rehabilitation With the Shoulder Pacemaker
Lead Sponsor:
University of Utah
Conditions:
Shoulder Injuries
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigators purpose of the proposed study is to use the FDA approved Shoulder Pacemaker device in patients undergoing reverse shoulder arthroplasty and study the functional outcomes compared to ...
Detailed Description
The reverse shoulder arthroplasty (RSA) has increased utility in recent years for shoulder conditions such as rotator cuff tear arthropathy, massive irreparable rotator cuff tears, severe glenohumeral...
Eligibility Criteria
Inclusion
- Patients indicated for primary reverse shoulder arthroplasty
- Surgery at University of Utah Facilities
- Patients between the ages 18-80.
Exclusion
- Prior ipsilateral shoulder arthroplasty
- Inability or unwillingness to participate in the rehabilitation protocol
- Prior cardiac pacemaker or spinal cord stimulator
- Age over 80
- History of periscapular surgery
- History of ipsilateral neurologic injury
- Prisoners
- Patients requiring prolonged immobilization deviating from standard protocol
- Patients who have an implantable medical device or other electrical device.
Key Trial Info
Start Date :
August 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06501859
Start Date
August 2 2023
End Date
July 1 2027
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah Orthopedics
Salt Lake City, Utah, United States, 84108